Rapid developments in muscle-invasive bladder cancer treatment are leading to new approaches to bladder preservation.
Now cancer-free, Deion Sanders reflected on the difficult days that followed his bladder cancer diagnosis last year. Sanders, ...
The Colorado football coach is reflecting on the past year as he looks forward to the coming season ...
Bladder cancer remains one of the most frequently diagnosed urologic malignancies worldwide, imposing a heavy and persistent ...
Last college football season was not easy for Colorado Buffaloes head coach Deion Sanders, and it wasn't just because it was ...
A year after undergoing surgery to remove his cancerous bladder, Deion Sanders is not only feeling younger and better, but he says he’s now living without cancer. Sanders, 58, told The Associated ...
Bladder cancer is often mistaken for UTIs, these are the 'painless' symptoms you should never ignore
Bladder cancer is often mistaken for UTIs with a urologist outliningg a list of 'painless' symptoms you should never ignore.
Recently published Non-muscle Invasive Bladder Cancer Market Insights report includes a comprehensive understanding of ...
NDV-01 Phase 2 NMIBC results, Phase 3 mid-2026 outlook, competition, and $160m financing—read the full analysis.
Please provide your email address to receive an email when new articles are posted on . The FDA approved durvalumab plus Bacillus Calmette-Guérin for adults with BCG-naive, high-risk non-muscle ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved atezolizumab for certain patients with muscle invasive bladder cancer. Results of a phase 3, ...
AstraZeneca’s first foray with PD-L1 inhibitor Imfinzi as a treatment for bladder cancer was a flop. After gaining accelerated approval in the indication in 2017, the company grudgingly clawed back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results